Variant report
Variant | nsv1070 |
---|---|
Chromosome Location | chr13:64672656-64718365 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs272361 | chr13:64674083-64674084 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs199646505 | chr13:64674095-64674096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568014113 | chr13:64674107-64674108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535152292 | chr13:64674120-64674121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555236188 | chr13:64674142-64674143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573493732 | chr13:64674264-64674265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534380713 | chr13:64674277-64674278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7490780 | chr13:64674285-64674286 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs567603174 | chr13:64674296-64674297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574924104 | chr13:64674313-64674314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536243959 | chr13:64674315-64674316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74620666 | chr13:64674321-64674322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561660444 | chr13:64674332-64674333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200830211 | chr13:64674334-64674335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544258443 | chr13:64674355-64674356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562643490 | chr13:64674357-64674358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574486551 | chr13:64674384-64674385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541897471 | chr13:64674416-64674417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186652421 | chr13:64674438-64674439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527565571 | chr13:64674455-64674456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191040744 | chr13:64674488-64674489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574059610 | chr13:64674507-64674508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564235555 | chr13:64674532-64674533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373474969 | chr13:64674542-64674543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531540610 | chr13:64674603-64674604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182006011 | chr13:64674608-64674609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145988549 | chr13:64674645-64674646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112389160 | chr13:64674650-64674651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186542720 | chr13:64674670-64674671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553780453 | chr13:64674703-64674704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191079795 | chr13:64674735-64674736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113190423 | chr13:64682803-64682804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529348136 | chr13:64682810-64682811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547917667 | chr13:64682824-64682825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183810817 | chr13:64682836-64682837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9317383 | chr13:64682840-64682841 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs558070183 | chr13:64682841-64682842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9317384 | chr13:64682937-64682938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs574043005 | chr13:64682939-64682940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371056386 | chr13:64682968-64682969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113983323 | chr13:64682980-64682981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551324716 | chr13:64683017-64683018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187980379 | chr13:64683084-64683085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117893301 | chr13:64683111-64683112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192409304 | chr13:64683121-64683122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140261161 | chr13:64683161-64683162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144180083 | chr13:64683168-64683169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs272347 | chr13:64683185-64683186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs369176397 | chr13:64683209-64683210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147969665 | chr13:64683228-64683229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64674000-64674800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr13:64682800-64683800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr13:64683000-64683600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:64695000-64695800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr13:64695600-64695800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr13:64695800-64706200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr13:64697200-64698400 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr13:64701800-64702400 | Enhancers | HUVEC | blood vessel |
9 | chr13:64704400-64706000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr13:64704600-64705000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr13:64704600-64705000 | Enhancers | Fetal Muscle Trunk | muscle |
12 | chr13:64704600-64705000 | Enhancers | HSMM | muscle |
13 | chr13:64704600-64705400 | Enhancers | Adipose Nuclei | Adipose |
14 | chr13:64704600-64705600 | Enhancers | Fetal Muscle Leg | muscle |
15 | chr13:64705000-64705600 | Enhancers | HSMMtube | muscle |
16 | chr13:64705600-64706800 | Weak transcription | Fetal Muscle Leg | muscle |
17 | chr13:64706200-64706400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |